Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies
Theranostics · 2024
DOI: 10.7150/thno.100116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Shadi A Esfahani und 25 weiteren Autor:innen. Beteiligte Einrichtung: Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Collagen Type I, Magnetic Resonance Imaging, Pancreatic Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
- Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
- Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
- Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Thoracic Surgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Gastrointestinal and Oncologic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
Zitieren
APA
Esfahani, S. A., Ma, H., Krishna, S., Shuvaev, S., Sabbagh, M., Deffler, C., Rotile, N., Weigand-Whittier, J., Zhou, I. Y., Catana, C., Catalano, O. A., Ting, D. T., Heidari, P., Abston, E., Lanuti, M., Boland, G. M., Pathak, P., Roberts, H., Tanabe, K. K., …, & Caravan, P. (2024). Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies. Theranostics. https://doi.org/10.7150/thno.100116
Vancouver
Esfahani SA, Ma H, Krishna S, Shuvaev S, Sabbagh M, Deffler C, et al. Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies. Theranostics. 2024. doi:10.7150/thno.100116
BibTeX
@article{Esfahani2024,
author = {Esfahani, Shadi A and Ma, Hua and Krishna, Shriya and Shuvaev, Sergey and Sabbagh, Mark and Deffler, Caitlin and Rotile, Nicholas and Weigand-Whittier, Jonah and Zhou, Iris Y and Catana, Ciprian and Catalano, Onofrio A and Ting, David T and Heidari, Pedram and Abston, Eric and Lanuti, Michael and Boland, Genevieve M and Pathak, Priyanka and Roberts, Hannah and Tanabe, Kenneth K and Qadan, Motaz and Castillo, Carlos Fernandez-Del and Shih, Angela and Parikh, Aparna R and Weekes, Colin D and Hong, Theodore S and Caravan, Peter},
title = {Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.100116}
}
EUVIMED